Track the 基蛋生物 share price and the full insider trade history of the company, a listed issuer based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 基蛋生物 has recorded 3 insider filings. Market capitalisation: €4.2bn. The latest transaction was filed on 15 August 2025 (Sale). Among the most active insiders: 南京爱基商务信息咨询有限公司. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
基蛋生物 es una empresa del sector sanitario y farmacéutico, que cotiza en la Bolsa de Shanghái. Se centra en el desarrollo y la producción de diagnósticos médicos.